Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 7/20 | 0.45 |
| ▸ | SPHK2 | Q9NRA0 | 6/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | FASN | P49327 | 1/20 | 0.39 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11687578 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL11688324 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL7110587 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL8727383 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL8855730 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL5685367 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL11689950 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL11809342 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL8855705 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL8855707 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10202620-B2 | Synthesis of olefinic alcohols via enzymatic terminal hydroxylation | PROVIVI, INC. (US) | 2019-02-12 | — | — | US | disclosed |
| US-20170135343-A1 | AGRICULTURAL PHEROMONE COMPOSITIONS COMPRISING POSITIONAL ISOMERS | PROVIVI, INC. | 2017-05-18 | — | — | US | disclosed |
| US-20160108436-A1 | SYNTHESIS OF OLEFINIC ALCOHOLS VIA ENZYMATIC TERMINAL HYDROXYLATION | PROVIVI, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| WO-2015176020-A1 | SYNTHESIS OF OLEFINIC ALCOHOLS VIA ENZYMATIC TERMINAL HYDROXYLATION | PROVIVI, INC. (US) | 2015-11-19 | — | — | WO | disclosed |
| US-5683708-A | Composition of chemicals for manipulating the behavior of nun moth, Lymantria monacha (L.), and gypsy moth, Lymantria dispar (L.) | SIMON FRASER UNIVERSITY (CA) | 1997-11-04 | — | — | US | disclosed |
| US-5683708-A | Composition of chemicals for manipulating the behavior of nun moth, Lymantria monacha (L.), and gypsy moth, Lymantria dispar (L.) | SIMON FRASER UNIVERSITY (CA) | 1997-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160108436-A1 | SYNTHESIS OF OLEFINIC ALCOHOLS VIA ENZYMATIC TERMINAL HYDROXYLATION | CYP2E1, ADH5, CYP1A2 | ALDH1A1 155/4885TSHR 2674/4885THRB 1389/4885 |
| US-20170135343-A1 | AGRICULTURAL PHEROMONE COMPOSITIONS COMPRISING POSITIONAL ISOMERS | PTMS, PTAR1, WAPL | ALDH1A1 4338/4885TSHR 3636/4885THRB 2971/4885 |
| US-10202620-B2 | Synthesis of olefinic alcohols via enzymatic terminal hydroxylation | CYP2E1, ADH5, CYP1A2 | ALDH1A1 155/4885TSHR 2674/4885THRB 1389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.